Canaccord Genuity Reiterates a 'Buy' on Watson Pharmaceuticals (WPI); Recent Visit Confirms 'Top Idea' Thesis
Tweet
Share
E-mailGet Alerts WPI Hot Sheet
Price: $85.73 --0%
Rating Summary:
13 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
13 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Watson Pharmaceuticals (NYSE: WPI) price target of $90.00.
Analyst, Randall Stanicky, said, "We hosted a headquarters visit to WPI that included a detailed discussion of the business with WPI’s senior executive team. The meeting theme was “comfort in numbers” – with three broad areas of focus: (1) only limited exposure to EU headwinds despite concerns we think the stock is caught up in; (2) synergy upside from the Actavis deal that could be material; and (3) a better understanding of standalone Watson EPS though Gx Lidoderm timing is still a swing factor. Bottom line, Watson remains our top idea."
For an analyst ratings summary and ratings history on Watson Pharmaceuticals click here. For more ratings news on Watson Pharmaceuticals click here.
Shares of Watson Pharmaceuticals closed at $70.46 yesterday.
Analyst, Randall Stanicky, said, "We hosted a headquarters visit to WPI that included a detailed discussion of the business with WPI’s senior executive team. The meeting theme was “comfort in numbers” – with three broad areas of focus: (1) only limited exposure to EU headwinds despite concerns we think the stock is caught up in; (2) synergy upside from the Actavis deal that could be material; and (3) a better understanding of standalone Watson EPS though Gx Lidoderm timing is still a swing factor. Bottom line, Watson remains our top idea."
For an analyst ratings summary and ratings history on Watson Pharmaceuticals click here. For more ratings news on Watson Pharmaceuticals click here.
Shares of Watson Pharmaceuticals closed at $70.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- Benchmark Reiterates Buy Rating on NVIDIA (NVDA), Updates Estimates
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
